Drugs & TargetsFree Philips and Illumina to co-develop integrated genomics solutions for oncology January 13, 2017Vol.43 No.02
Drugs & TargetsFree Tecentriq receives priority review for treatment of urothelial carcinoma January 13, 2017Vol.43 No.02
Drugs & TargetsFree EMD Serono and MD Anderson enter three-year collaboration January 13, 2017Vol.43 No.02
Drugs & TargetsFree MD Anderson and Deerfield Management create company to inhibit autophagy January 13, 2017Vol.43 No.02
Drugs & TargetsFree Cologuard earns positive review from Blue Cross Blue Shield Association January 13, 2017Vol.43 No.02
Drugs & TargetsFree FDA accepts BLA for Mylan and Biocon’s biosimilar Trastuzumab January 13, 2017Vol.43 No.02
Drugs & TargetsFree FDA releases guidance on nonproprietary naming of biologics January 13, 2017Vol.43 No.02
FreeIn Brief Sakaguchi, Ramsdell, Rudensky win Crafoord Prize for discoveries in immune regulation January 13, 2017Vol.43 No.02
FreeIn Brief Gustavo Leone named director of MUSC Hollings Cancer Center January 13, 2017Vol.43 No.02
FreeIn Brief Levine Cancer Institute is first to earn top designation for patient-centered care January 13, 2017Vol.43 No.02
